—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Alkermes Plc (ALKS) — Technical state

As of 2026-11-02 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.

The Closelooknet read

  • Closelooknet score: 52 out of 100 (momentum 62 · quality 53 · valuation 22), as of 2026-11-03.
  • Signal: Uptrend stack intact — Trades +2.1% vs the 50-day and +10.7% vs the 200-day average, 19.4% below the 52-week high and +66.3% off the 52-week low. Computed from daily closes. (as of 2026-11-02)
  • Trend: Alkermes Plc trades 2.1% above its 50-day and 10.7% above its 200-day moving average. (as of 2026-11-02)

Alkermes develops and sells drugs for opioid dependence, alcohol dependence, schizophrenia and bipolar disorder, with an injectable suspension, an oral antipsychotic and a narcolepsy treatment among its marketed products. It also licenses manufacturing and delivery technology to other drugmakers and holds collaboration agreements with a major pharmaceutical partner.

The full read — the desk's view, the earnings record, peers and the company snapshot — is on the ALKS overview. Agents can buy the score depth per call over HTTP 402 — see the catalogue. Research diary readings, not advice.

Uptrend stack intact

Trades +2.1% vs the 50-day and +10.7% vs the 200-day average, 19.4% below the 52-week high and +66.3% off the 52-week low. Computed from daily closes.

The moving-average stack

Continue: the ALKS chart & overview · quality & forensics · the earnings record · the signal board

FAQ · from the current data · as of 2026-11-02

Quick answers

What is the current Closelooknet signal on ALKS?

Uptrend stack intact — Trades +2.1% vs the 50-day and +10.7% vs the 200-day average, 19.4% below the 52-week high and +66.3% off the 52-week low. Computed from daily closes. As of 2026-11-02; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.

Is ALKS above its 50-day and 200-day moving averages?

As of 2026-11-02, Alkermes Plc trades +2.1% above its 50-day and +10.7% above its 200-day average, with the 20-day +5.4% away.

How far is ALKS from its 52-week high?

19.4% below the 52-week high and 66.3% above the 52-week low, as of 2026-11-02.

Related in the Closelooknet universe

then Drug Manufacturers - Specialty & Generic. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.